Bio-Techne (TECH) EPS (Weighted Average and Diluted) (2009 - 2026)
Bio-Techne's quarterly EPS (Weighted Average and Diluted) came in at $0.32 in Q1 2026, up 128.57% year-on-year from $0.14 in Q1 2025, and up 33.33% quarter-over-quarter from $0.24 in Q4 2025.
Bio-Techne has reported EPS (Weighted Average and Diluted) for 18 years, with the latest figure at $0.32 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 128.57% year-over-year to $0.32; the trailing twelve-month figure through Mar 2026 stood at $0.69 (down 16.87% YoY), and the FY2025 full-year result was $0.46, down 56.19% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at $0.32, up from $0.24 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was $0.55 in Q3 2022, with the low at -$0.11 in Q2 2025.
- Average EPS (Weighted Average and Diluted) over 5 years is $0.28, with a median of $0.31 recorded in 2022.
- Year-over-year, EPS (Weighted Average and Diluted) sank 142.31% in 2025 and jumped 128.57% in 2026.
- Tracing TECH's EPS (Weighted Average and Diluted) over 5 years: stood at $0.31 in 2022, then slumped by 45.16% to $0.17 in 2023, then gained by 29.41% to $0.22 in 2024, then increased by 9.09% to $0.24 in 2025, then surged by 33.33% to $0.32 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at $0.32 (Q1 2026), $0.24 (Q4 2025), and $0.24 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -4.43 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,086.42 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 4.02 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 6.75 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.51 |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | 0.32 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.32 |
| Dec 31, 2025 | 0.24 |
| Sep 30, 2025 | 0.24 |
| Jun 30, 2025 | -0.11 |
| Mar 31, 2025 | 0.14 |
| Dec 31, 2024 | 0.22 |
| Sep 30, 2024 | 0.21 |
| Jun 30, 2024 | 0.26 |
| Mar 31, 2024 | 0.31 |
| Dec 31, 2023 | 0.17 |
| Sep 30, 2023 | 0.31 |
| Jun 30, 2023 | 0.46 |
| Mar 31, 2023 | 0.43 |
| Dec 31, 2022 | 0.31 |
| Sep 30, 2022 | 0.55 |
| Jun 30, 2022 | 0.38 |
| Mar 31, 2022 | 0.37 |
| Dec 31, 2021 | 0.49 |
| Sep 30, 2021 | 1.69 |
| Jun 30, 2021 | -2.24 |
| Mar 31, 2021 | 1.12 |
| Dec 31, 2020 | 1.15 |
| Sep 30, 2020 | 0.83 |
| Jun 30, 2020 | 1.48 |
| Mar 31, 2020 | 0.92 |
| Dec 31, 2019 | 3.02 |
| Sep 30, 2019 | 0.37 |
| Jun 30, 2019 | 0.42 |
| Mar 31, 2019 | 1.15 |
| Dec 31, 2018 | 0.45 |
| Sep 30, 2018 | 0.45 |
| Jun 30, 2018 | 1.07 |
| Mar 31, 2018 | 0.52 |
| Dec 31, 2017 | 1.29 |
| Sep 30, 2017 | 0.42 |
| Jun 30, 2017 | 0.74 |
| Mar 31, 2017 | 0.59 |
| Dec 31, 2016 | 0.20 |
| Sep 30, 2016 | 0.50 |
| Jun 30, 2016 | 0.69 |
| Mar 31, 2016 | 0.81 |
| Dec 31, 2015 | 0.69 |
| Sep 30, 2015 | 0.61 |
| Jun 30, 2015 | 0.70 |
| Mar 31, 2015 | 0.65 |
| Dec 31, 2014 | 0.89 |
| Sep 30, 2014 | 0.64 |
| Jun 30, 2014 | 0.73 |
| Mar 31, 2014 | 0.85 |
| Dec 31, 2013 | 0.68 |
| Sep 30, 2013 | 0.74 |
| Jun 30, 2013 | 0.77 |
| Mar 31, 2013 | 0.90 |
| Dec 31, 2012 | 0.69 |
| Sep 30, 2012 | 0.70 |
| Jun 30, 2012 | 0.74 |
| Mar 31, 2012 | 0.86 |
| Dec 31, 2011 | 0.70 |
| Sep 30, 2011 | 0.74 |
| Jun 30, 2011 | 0.76 |
| Mar 31, 2011 | 0.84 |
| Dec 31, 2010 | 0.71 |
| Sep 30, 2010 | 0.71 |
| Jun 30, 2010 | 0.69 |
| Mar 31, 2010 | 0.87 |
| Dec 31, 2009 | 0.66 |
| Sep 30, 2009 | 0.72 |